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Abstract: Cheese Whey Permeate (CWP) is the by-product of whey ultrafiltration for protein recovery.
It is highly perishable with substantial disposal costs and has serious environmental impact. The aim
of the present study was to develop a novel and cheap CWP-based culture medium for Lactobacillus
sakei to produce the food-grade sakacin A, a bacteriocin exhibiting a specific antilisterial activity.
Growth conditions, nutrient supplementation and bacteriocin yield were optimized through an
experimental design in which the standard medium de Man, Rogosa and Sharpe (MRS) was taken
as benchmark. The most convenient formulation was liquid CWP supplemented with meat extract
(4 g/L) and yeast extract (8 g/L). Although, arginine (0.5 g/L) among free amino acids was depleted
in all conditions, its supplementation did not increase process yield. The results demonstrate the
feasibility of producing sakacin A from CWP. Cost of the novel medium was 1.53 €/L and that of
obtaining sakacin A 5.67 €/106 AU, with a significant 70% reduction compared to the corresponding
costs with MRS (5.40 €/L, 18.00 €/106 AU). Taking into account that the limited use of bacteriocins for
food application is mainly due to the high production cost, the obtained reduction may contribute to
widening the range of applications of sakacin A as antilisterial agent.
Keywords: cheese whey permeate; sakacin A; bacteriocin; Listeria; bioprocess; circular
economy; fermentation
1. Introduction
The new concept of healthy food is boosting the use of natural compounds as alternatives
to chemical preservatives in preventing bacterial deterioration [1]. Bio-preservation exploit
non-pathogenic microorganisms and their metabolites having antimicrobial effect [2]; in this frame,
bacteriocins can be good candidate compounds as long as they lack toxic effects to humans [3,4].
Chemically, bacteriocins are small proteins or peptides, heat-stable, active at acidic pH and, owing
to the low concentrations required, do not modify food flavour [3,5]. Numerous classifications have
been proposed based on their structure, mode of action, biochemical properties and post-translational
odifications [6], nevertheless, class I and II bacteriocins are the most studied. Their targets are mainly
foodborne pathogens such as Listeria monocytogenes, Staphylococcus aureus, Escherichia coli and Salmonella
spp. [5]. The main obstacle to widespread use of bacteriocins in food biopreservation is the high
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price of their commercial preparations due to the low fermentation yields and high production costs.
Complex growth media are needed, which often cannot be classified as food-grade. The MRS (de Man,
Rogosa and Sharpe) medium is currently considered as the most suitable for promoting the growth
of lactic acid bacteria (LAB). However, it is expensive and thus its use for industrial production of
bacteriocins appears unfeasible. An attractive approach to producing food-grade bacteriocins is to use
by-products of the agro-food industry in the formulation of culture media [3]. In this frame, cheese
whey (CW) and whey fermentations by LAB.
CW is obtained as a by-product of cheese manufacture. It represents around 90% of the initial
milk volume and contains soluble components, including lactose, whey proteins, peptides and amino
acids, minerals and water-soluble vitamins. Owing to their distinctive nutritional and functional
characteristics, whey proteins are mainly recovered from CW by ultrafiltration (UF) and become
ingredients for a variety of foods, pharmaceuticals and cosmetics [7]. The UF process generates a further
by-product, namely cheese whey permeate (CWP), that is highly perishable, has high disposal costs
and serious environmental impact [8,9], but at the same time, it retains valuable milk components [10].
Liquid CWP is partly destined to lactose production, but most is turned into powder [9]. As a
consequence of an expected increase in demand for whey protein concentrates, the availability of CWP
will grow as well [11–13], which may represent a resource for activating valuable circular economy
activities [14]. World CWP volume (in powder) is estimated in 855,000 Metric Tonnes (MT) in 2017, with
an expected increase by 4% Compound Annual Growth Rate (CAGR) over the period 2017–2027 [15].
The associated market value of world CWP production is worth in 598 Millions of Euro in 2017. Market
price for CWP powder was 0.7 €/kg in 2017 and is expected to increase up to 0.731 €/kg in 2027. Note
that these data refer to CWP powder cost, that incorporates the drying step; transformation in powder
is performed to make CWP transportable and storable. According to various experts’ opinion, the
price of liquid unprocessed CWP is in the range 1–1.5 cent €/L, including the refrigeration costs.
Therefore, using liquid or powder CWP depends on logistic evaluations, based on the
proximity between UF plants and the place in which CWP is used for circular bioeconomy activities.
The conversion of dairy industry effluents from waste to resources, with different options of management
and valorisation, has a long stand history [16,17]. However, the increasing societal demand for more
sustainable food manufacture processes has boosted the research in this field.
In particular, the use of CWP has been experimented as a substrate to obtain bioproducts having
different degrees of added value, such as lactic acid [18], biopolimers [19], biofuel and biogas [20,21] as
well as microalgae [22].
Listeria monocytogenes is a Gram-positive, facultative anaerobe, motile, non-spore forming, rod
shaped bacterium that has been known as the causative agent of listeriosis, a highly fatal opportunistic
foodborne infection. Listeriosis is rare, but its social and economic impact is one of the highest
among foodborne diseases [23]. Sakacin A, a bacteriocin produced by Lactobacillus sakei, as all class
IIa bacteriocins, primarily acts by permeabilizing Listeria membrane, dissipating (in term of seconds)
transmembrane potential (∆Ψ) and pH gradient (∆pH) through the formation of pores [6]. Other
sakacins have been identified and characterized from a variety of L. sakei strains, most of which
isolated from raw meat. Examples are sakacin M, P, 674, B and K [24]. Sakacin A presents a 100%
sequence identity with the bacteriocin produced from Lactobacillus curvatus, curvacin A. Although
these two proteins could be considered equivalent under a molecular point of view, small differences
are reported in the gene cluster organization [25]. Recently, it has been highlighted that sakacin A
can find application in preserving food items potentially contaminated with Listeria monocytogenes,
such as ready-to-eat products, with the bacteriocin successfully incorporated in food packaging
material [26–28]. It is worth noting that the market value of the antimicrobial packaging sector is
currently 29.0 billion US$ [29,30], supporting the interests of the food industry in this new technology.
Economic feasibility of this approach, however, strongly lies in market availability of food-grade
bacteriocins at relatively low cost.
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The aim of the present study was to develop a novel and cheap CWP-based food-grade culture
medium for L. sakei to produce sakacin A. Growth conditions of the strain, nutrient supplementation
and bacteriocin yield were optimized. Liquid CWP was used as the basic ingredient in view of
establishing a bioprocess that can be easily scaled up, avoiding CWP concentration and drying costs.
2. Materials and Methods
2.1. Microorganisms and Maintenance
Lactobacillus sakei DSMZ 6333 (Lb706) (DSMZ: Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH, Braunschweig, Germany) was the sakacin-A-producing strain while Listeria
innocua DSMZ 20649 was the target strain. The two strains were maintained on MRS broth
(DeMan-Rogosa-Sharpe, Merck K GaA, Darmstadt, Germany) and on TSB (Tryptic Soy Broth; Merck K
GaA) inoculating media (10% v/v) respectively. A pre-grown culturing and incubation in stationary
condition for 16 h were carried out at 30 ◦C for L. sakei and 37 ◦C for L. innocua. Stock cultures of
both microorganisms were stored at −80 ◦C in the medium added with 20% (v/v) glycerol (VWR
International, Leuven, Belgium). Cultures were propagated twice before use.
2.2. Quantification of Sakacin a Activity
Antimicrobial activity of sakacin A was evaluated by the agar diffusion assay, as reported in
Mapelli et al. [29]. Briefly, aliquots of overnight Listeria culture were added to soft TSA (TSB added
with 8 g/L agar) in a Petri dish, then cell-free supernatant of L. sakei culture was properly diluted and
poured in wells previously made on the plate. Plates were incubated overnight at 37 ◦C and sakacin A
production was quantified as Activity Units per medium (AU/mL) according to Trinetta et al. [30] or,
alternatively, as the measure (mm) of inhibition halo around the wells.
2.3. Lactobacillus Sakei Growth Evaluation
A culture medium for L. sakei (SAK-medium) was initially used, having the following composition:
meat extract, ME (VWR) 8 g/L; yeast extract, YE (Costantino srl, Turin, Italy) 8 g/L; arginine, ARG
(Merck K GaA) 0.5 g/L; Tween-80 (Merck K GaA) 0.5 mL/L, minerals and vitamins mix 1 mL/L as
reported by Mapelli et al. [27]. Ingredients were dissolved in liquid CWP, kindly supplied by Latteria
Soresina (Soresina, Italy).
Freshly produced CWP was collected at the cheese factory from the UF plant that processes whey
from hard cheese manufacture, immediately frozen and kept at −20 ◦C until use. The CWP batch had
a lactose content of 42 g/L and pH 6.2 and was filter sterilized just before use.
Both L. sakei growth and sakacin A production were determined in the SAK-medium and in MRS,
being the latter taken as benchmark. L. sakei growth was studied at 26◦C with different percentage of
inoculum, i.e., 0.1, 0.5, 1 and 5% (v/v). Culture turbidity (OD) was measured spectrophotometrically at
600 nm every 15 min in a PowerWave™ XS2 Microplate Spectrophotometer (BioTek, Winooski, VT,
USA); lag phase (min) and maximum growth rate (OD/h) were determined fitting data through the
Baranyi and Roberts model [31] on DMFit 3.5 Excel add-in.
2.4. Sakacin-A Production and Process Optimization
A general full factorial design with 3 variables was set-up to identify components and/or
interactions having significant effect on sakacin A production; the chosen levels were as follows: A-ME
0–4–8 g/L; B-YE 0–4–8 g/L; C-ARG 0–0.5–1 g/L; these concentrations were chosen in order to maximize
production of sakacin A while possibly reducing the cost of the culture medium. The 27 combinations
were tested in duplicate, giving rise to a total of 54 trials. Culture formulations were all inoculated
with a pre-grown L. sakei liquid culture and incubated at 26 ◦C to promote bacteriocin production.
Multiple factors interactions were determined employing Design Expert® v. 12.0 software
(Stat-Ease Inc., Minneapolis, MN, USA), combined with the Student t test to evaluate whether given
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terms had significant effect (p ≤ 0.05). Results were monitored in terms of pH value, measured with
a pH-meter (FiveEasy™, Mettler Toledo, Schwerzenbach, Swiss), lactic acid production, amino acid
consumption, as well as bacteriocin production, measured in terms of diameter (mm) of the inhibition
halo. Quality of fitted model equations was expressed by the regression coefficient R-square. Statistical
parameters and interactions significance were verified by the analysis of variance (ANOVA). Parametric
estimations, calculated from the results, were carried out by minimizing the sum of quadratic differences
between observed and model-predicted values, using the non-linear least-squares procedure.
2.5. Lactic Acid and Amino Acids Determinations
Lactic acid was determined in the culture media after centrifugation and filtration of the
supernatant. An HPLC system (Merck-Hitachi L-7000 System) was used, equipped with an UV
detector (210 nm), using a (300 × 8 mm) SH1821 column (Shodex, München, Germany), maintained at
50 ◦C and eluted with 5 mM H2SO4 at 0.5 mL/min.
Free amino acids, including added arginine, were analysed in culture sample supernatants that
were further adjusted to pH 2.2 and filtered. A Biochrom 30+ automatic amino acid analyser (Biochrom
Ltd., Cambridge, UK) was used and elution conditions recommended by the manufacturer were
adopted. A 14-step elution program with six lithium citrate buffers of increasing pH and ionic strength
was adopted, with post-column derivatization with ninhydrin and detection at 440 and 570 nm.
Five-level calibration curves were used for amino acid quantification [32].
3. Results and Discussion
3.1. L. Sakei Growth and Sakacin a Production in MRS and SAK Media
The optimized process for sakacin A production, using CWP as a substrate, refers to a lab-scale
cost minimization consideration. Process optimization, based on lab-scale cost minimization, may
present some limitations. First, lab-scale production costs include only the cost of ingredients for
medium formulation. Given the small production scale, energy, labor and fixed costs associated with
lab facilities, are not included in the computation. Such omitted costs, may lead to an increase in
the total costs when production is up-scaled from lab-level to pilot- and plant-level. On the other
hand, up scaling the production usually brings to a decrease in average cost of production, for the
well-known phenomenon of economies of scale. Such relationship is due to both, technological
and market reasons. The technological reasons are explained by the increasing return to scale: an
increase of 1% in production inputs (labour, ingredients and machinery/plants) brings to a production
increase bigger than 1%. Market reasons that contributes to economies of scale, relate to the decreasing
procurement costs of variable inputs: Growth of production increases the demand of ingredients for the
medium, which in turn reduces their buying price for the plant. All the above mentioned explanations
point out that lab-scale production costs are not necessarily a good forecast of plant-level production
costs, even if, usually, the former are higher of the latter. Another limitation of optimization, based on
lab-scale production costs, is the comparability across processes in different market conditions. The
production cost is computed by multiplying the quantity of each ingredient used in 1 L of medium, per
unit cost (price). For this reason, production cost of processes presented in this paper are comparable
among them and with other process of production of sakacin A only under the assumption of equal
price (per-unit cost) of the ingredients used in the medium. Nevertheless, to ensure comparability
among production processes in this paper and from other authors, we provide the composition of
each medium/formulation, so that, for each process, the production cost can be recomputed based on
different market prices of each ingredient.
The initial formulation of SAK-medium, the prices of all ingredients used in the present analysis
as well as that of MRS, taken on the basis of their cost at lab scale, are shown in Table 1. Meat extract
(ME), yeast extract (YE) and Tween 80 are also present in MRS, the first two to support microbial
growth, while Tween 80 reduces the mean particle size and polydispersity index of ingredients, thus,
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allowing a fastest microbial uptake [33]. All minerals present in MRS (sodium acetate, MgSO4, MnSO4,
ammonium citrate, potassium phosphate) were avoided and replaced by those naturally present in
CWP. The initial concentration of ME, YE and the other ingredients, dissolved in CWP, have been
chosen on the basis of previously published data [26,27]. The presence of arginine was evaluated to
investigate the possibility of promoting the arginine deiminase (ADI) pathway, adopted by a variety of
bacterial species for obtaining further ATP for cell growth and NH3 that helps in maintaining the pH
to physiological levels. The enzymes involved in the ADI pathway catalyze the conversion of arginine
to citrulline, NH3 and CO2, while generating ATP. Citrulline can be further metabolized into ornithine
and carbamoyl-phosphate [34].
Table 1. Ingredients cost of MRS (benchmark) and SAK culture media (lab scale).
Medium Ingredient Cost €/Kg g/L €/L Share of SAK Cost (%)
MRS As purchased 104 52.2 5.40 -
SAK Yeast Extract 60 8 0.48 21
Meat Extract 149 8 1.19 52
Arginine 415 0.5 0.20 9
Tween-80 83.7 0.5 0.04 2
Vitamin mix 0.37 €/mL 1 mL 0.37 16
CWP 0.015 €/L 1 L 0.015 1
TOTAL 2.30 100
Based on this composition, the SAK-medium was cheaper (−58%) than MRS, i.e., 2.30 and 5.40 €/L,
respectively. Furthermore, the cost share of CWP on total cost of SAK was the lowest among ingredients,
confirming CWP as a potential cheap substrate.
L. sakei growth was monitored comparatively in SAK and MRS media differently inoculated
(0.1–0.5–1–5% v/v) (Figure 1). Analyses of the fitted growth curves identified L. sakei lag phase (h),
growth rate (OD/h) and final OD value (Table 2).
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Figure 1. L. sakei DSM 6333 growth in MRS (left) and SAK (right) formulation at 26 ◦C. Different curves
correspond to different percentage of inoculum (v/v), from 0.1% (light grey) to 5% (black).
As expected, the lag phase significantly decreased with the increase of inoculum percentage
for both media and, regardless to the inoculum, longer in SAK. Even if slightly higher L. sakei
growth (final OD) was obtained in MRS, growth rates were always higher in SAK, highlighting that
the formulation containing CWP can effectively support L. sakei growth. The quantification of the
antimicrobial activity confirmed that the highest sakacin A production was reached at the end of
the exponential phase of each curve [27,35], i.e., at 8 h for cultures inoculated at 5% (v/v) (300 and
333 AU/mL in MRS and SAK respectively) and 16 h for 0.1–0.5% (v/v) (233–267 AU/mL).
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Table 2. L. sakei growth curves fitting parameters in MRS and SAK media differently inoculated
(from 0.1 to 5% v/v).
Inoculum
Medium
0.1% (v/v)
MRS SAK
0.5% (v/v)
MRS SAK
1% (v/v)
MRS SAK
5% (v/v)
MRS SAK
Lag phase
(h)
mean 3.267 A 5.266 B 2.581 A 3.794 B 1.854 A 2.895 B 0.010 A 1.839 B
std. dev 0.009 0.109 0.063 0.111 0.083 0.061 0.010 0.067
Growth rate
(OD/h)
mean 0.200 A 0.255 B 0.219 A 0.239 B 0.237 A 0.250 B 0.241 A 0.306 B
std. dev 0.009 0.004 0.007 0.002 0.009 0.002 0.014 0.009
Final Value
(OD)
mean 1.517 B 1.459 A 1.550 B 1.452 A 1.558 B 1.496 A 1.613 B 1.534 A
std. dev 0.031 0.013 0.005 0.063 0.016 0.018 0.019 0.005
Sakacin A AU/mL 267 233 267 233 267 267 300 333
Time (h) 16 16 16 16 12 12 8 8
Values with different superscripts uppercase (A, B) letter within the same raw are significantly different (p < 0.05).
3.2. Optimization of SAK Medium Formulation
Different formulations of the initial SAK medium were tested with the possibility of reducing
their amount, in order to further reduce sakacin A production costs. Ingredients were evaluated
for their influence on pH decrease, lactic acid and sakacin A production (Table 3). As previously
explained, pH time course cannot be considered totally representative of sakacin A production due
to the possible activation of the ADI pathway with consequent NH3 production. On the contrary,
as lactic acid production is directly linked to bacterial growth, its concentration can be correlated to
the presence of sakacin A [27]; concentrations of lactic acid higher than 2 g/L were found when YE
concentration was set at its maximum level and above all when in presence of ME, while arginine
seems not to be correlated with microbial growth and lactic acid production.
Table 3. Arrangement of the experimental design performed with L. sakei grown at 26 ◦C for 16 h
(ME-Meat Extract, YE-Yeast Extract, Arg-arginine) and observed responses: Culture pH, lactic acid
concentration (g/L) and sakacin A production (expressed as inhibition halo-mm-vs. L. innocua).
Trial
A-ME
(g/L)
B-YE
(g/L)
C-Arg
(g/L)
Culture pH Lactic Acid (g/L) Sakacin A Prod. (mm)
Mean Std. dev Mean Std. dev. Mean Std. dev
1 0 0 0.5 6.32 0.04 0.01 0.00 0.0 0.0
2 0 4 0.5 5.15 0.07 1.35 0.00 7.0 0.0
3 0 8 0.5 5.02 0.09 1.84 0.21 9.5 0.7
4 4 0 0.5 6.18 0.02 0.68 0.00 8.0 0.0
5 4 4 0.5 5.64 0.00 1.56 0.01 9.5 0.7
6 4 8 0.5 5.14 0.16 2.35 0.13 11.5 0.7
7 8 0 0.5 6.18 0.04 0.98 0.01 10.0 0.0
8 8 4 0.5 5.72 0.00 1.81 0.05 11.5 0.7
9 8 8 0.5 5.35 0.03 2.59 0.02 13.0 0.0
10 0 0 1 6.49 0.02 0.01 0.00 0.0 0.0
11 0 4 1 5.23 0.19 1.20 0.18 3.0 0.0
12 0 8 1 5.16 0.11 1.70 0.33 8.0 0.0
13 4 0 1 6.45 0.05 0.80 0.01 7.5 0.7
14 4 4 1 5.97 0.10 1.57 0.05 10.0 0.0
15 4 8 1 5.44 0.18 2.47 0.04 11.5 0.7
16 8 0 1 6.49 0.04 1.03 0.06 10.0 0.0
17 8 4 1 6.06 0.01 1.88 0.04 11.0 0.0
18 8 8 1 5.63 0.15 2.66 0.13 12.0 0.0
19 0 0 0 6.10 0.01 0.03 0.01 0.0 0.0
20 0 4 0 4.99 0.06 1.33 0.10 7.0 0.0
21 0 8 0 4.85 0.05 1.93 0.00 9.5 0.7
22 4 0 0 5.54 0.07 0.69 0.06 7.5 0.7
23 4 4 0 5.13 0.11 1.45 0.07 9.0 0.0
24 4 8 0 4.90 0.07 2.11 0.26 10.5 0.7
25 8 0 0 5.63 0.04 0.90 0.06 8.5 0.7
26 8 4 0 5.24 0.04 1.74 0.06 10.5 0.7
27 8 8 0 5.05 0.04 2.44 0.07 11.5 0.7
MRS - - - 4.45 0.10 5.62 0.18 13.0 0.7
ANOVA analyses identified as significant positive terms A-ME, B-YE and the combination AB
(Table 4); as expected, in pH responses as expected the term C-Arg and the interactions AC and BC
were found significant; as for sakacin A production, all the terms and interactions resulted significant.
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Model adaptation goodness, variability and noise ratio were found adequate for all the three models
identified by the software. Figure 2 reports the interaction plots obtained with observed-predicted pH
values, lactic acid concentration levels and sakacin A production obtained in trials performed without
(i) or with 0.5 g/L (ii) and 1 g/L (iii) arginine.
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Figure 2. Interactions plots: responses related to culture pH (first row), lactic acid (second row)
and sakacin A production (third row, expressed as inhibition halo vs. Listeria) in supernatants of L.
sakei. Factors: A-ME (Meat Extract) at 0-4-8 g/L on X-axis; B-Y (Yeast Extract) at 0 g/L (red)–4 g/L
(green)–8 g/L (bl e); results obtained without arginine (first column), with arginin set at 0.5 g/L (s c
l ) / (t i l ).
Th lowest pH levels were always associat d with the highe YE conc tration (blue line), while
a low influenc of ME w s observed. As expected, higher pH le els were evidenced in trials with
arginine, confirming the activation of the ADI pathway.
Both, lactic acid and sakacin A pro u tions, wer at their l west level when no YE and ME
were added, i.e., when m crobial growth was limited. A direct cor lation was evident between the
concentration of t ese two i gredients and lactic acid p oduction, YE being m re influent than ME on
L. sakei growth and bacteriocin production. This ingr dient, due to the pr s nce of amino acids nd
peptid s, has lready been reported to promote LAB cell growth [4].
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Table 4. ANOVA response, effect estimates, models adaptation goodness as well as variability and noise
ratio for each of the observed responses (pH, lactic acid and sakacin A production) of the experimental
design reported in Table 3 (α-out: 0.05).
Parameter pH Lactic Acid Sakacin AProduction
Model p < 0.0001Linear p < 0.0001 Square root
p < 0.0001
Linear
A-ME p < 0.0001 p < 0.0001 p < 0.0001
B-YE p < 0.0001 p < 0.0001 p < 0.0001
C-Arg p < 0.0001 ns * p < 0.0001
AB p < 0.0001 p < 0.0001 p < 0.0001
AC p < 0.0001 ns p < 0.0001
BC p 0.0093 ns p 0.0040
ABC ns ns p 0.0008
Lack of fit 0.457 ns 0.1066 ns - (Saturated)
Model std. dev 0.086 0.048 0.047
mean 5.59 1.13 0.85
C.V.% 1.53 4.25 5.56
R2 0.9828 0.9894 0.9916
Adj R2 0.9740 0.9875 0.9834
Pred R2 0.9591 0.9847 0.9663
Adeq precision 32.449 75.839 39.000
* ns: not significant, p value > 0.0500.
The analysis of free amino acids was also performed (Table 5): Trials containing 0.5 g/L arginine
(Table 3, Run 9) and the correspondent, without (Table 3, Run 27) evidence that arginine was totally
depleted in both samples, as expected, and ornithine steeply increased. Cysteine and glutamine were
absent either at t0 and at the end of incubation in both the formulation without or with arginine.
Table 5. Free amino acid concentration (mg/L) at t0 and 16 h incubation and percent variation in L.
sakei grown cultures in SAK medium without or with L-arginine addition (0.5 g/L). Data reported as
means, CV in the range 7–12%.
Amino Acid YE 8-ME 8-ARG 0 YE 8-ME 8-ARG 0.5
(mg/L) t0 16 h (%) t0 16 h (%)
Alanine 171.0 183.8 7 169.3 183.4 8
Arginine 194.0 0.0 −100 526.0 0.0 −100
Asparagine 78.0 63.6 −18 76.5 56.7 −26
Aspartate 138.4 127.8 −8 137.5 131.9 −4
Citrulline 26.5 24.1 −9 25.8 24.9 −3
Cysteine 0.0 0.0 0 0.0 0.0 0
GABA 10.2 10.4 2 10.1 10.5 4
Glutamine 0.0 0.0 0 0.0 0.0 0
Glutamate 402.6 429.9 7 392.3 423.6 8
Glycine 70.0 89.0 27 69.1 89.9 30
Histidine 44.2 49.3 12 45.8 50.6 10
Isoleucine 131.7 175.4 33 129.9 175.9 35
Leucine 254.5 296.0 16 251.2 293.5 17
Lysine 189.5 216.8 14 185.7 214.9 16
Methionine 50.2 51.9 3 48.0 53.0 10
Ornithine 15.8 142.4 802 15.1 233.8 1449
Phenilalanine 180.3 201.1 12 180.6 202.4 12
Proline 52.8 70.2 33 52.0 71.3 37
Serine 98.4 11.4 −88 94.5 5.2 −95
Threonine 89.4 124.9 40 88.7 117.9 33
Tryptophan 40.1 54.1 35 39.6 54.4 37
Tyrosine 95.7 141.4 48 138.8 180.7 30
Valine 176.6 221.1 25 177.2 220.7 25
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Serine was found to sharply decrease during cell growth of about −98, and −85%, respectively in
samples without and with arginine. Serine decrease during L. sakei growth may indicate the possible
existence of metabolic routes aimed to produce energy; serine conversion into pyruvate has been
described in P. pentosaceus due to the action of a serine dehydratase [36].
McLeod et al. [37] observed a drastic utilization of serine and asparagine in L. sakei strains grown
under glucose limiting conditions. Montanari et al. [38] calculated a 30% decrease of the serine +
asparagine concentration in L. sakei cultured in MRS medium; here, a 55% decrease of this amino acid
association was evidenced with no significant difference related to the presence of arginine.
The optimization approach suggested by the software (desirability higher than 0.800) to maximize
sakacin A and lactic acid production while minimizing pH, resulted in 7 medium formulations,
reported in Table 6 together with their respective formulation cost (€/L), sakacin A production yield
(AU/L) and production cost (€/106 AU).
Table 6. Media formulations calculated by the optimization process (Design Expert®, desirability
>0.800), maximizing lactic acid and sakacin A production: estimated cost of formulation (€/L), sakacin
A production yield (106 AU/L) and cost (€/106 AU) reported and compared with those obtained with
MRS (benchmark).
Medium ME(g/L)
YE
(g/L
Arg
(g/L) pH
Lactic Acid
(g/L) Desirability
Medium
Cost (€/L)
Sak. A Yield
(106 AU/L)
Sak. A Cost
(€/106 AU)
1 (SAK) 8 8 0.5 5.35 2.56 0.907 2.30 0.289 7.96
2 8 8 0 5.09 2.56 0.907 2.13 0.242 8.80
3 4 8 0 4.84 2.30 0.878 1.53 0.270 5.67
4 4 8 0.5 5.16 2.30 0.870 1.73 0.278 6.22
5 0 8 0.5 4.98 1.82 0.825 1.14 0.190 7.37
6 4 8 1 5.47 2.30 0.823 1.93 0.233 8.28
7 8 8 1 5.65 2.56 0.819 2.53 0.233 10.86
MRS - - - 4.45 5.62 - 5.40 0.300 18.00
Keeping in mind the final goal of the present work, the most convenient SAK formulation was
found composed by ME at 4 g/L, YE at 8 g/L and no arginine, having a formulation cost of around
1.53 €/L and an estimated sakacin A cost of around 5.67 €/106 AU. Compared with the values obtained
in MRS (5.40 €/L, 18.00 €/106 AU), a 70% decrease in the production costs was reached in this study.
Mapelli et al. [27] employing the non-optimized SAK formulation, resulted in 2.33 €/L and 8.06 €/106
AU, around 30% higher. Trinetta et al. [30] reported, for sakacin A, higher production costs (2.9 €/L),
50% more expensive medium containing bacto peptone, meat peptone, cheese whey, yeast autolysate,
glucose and calcium carbonate.
Even if prices are calculated on the basis of ingredients purchased in lab-scale mass, difference in
cost among the selected formulations still can be compared to identify the most convenient choice.
Note also, that when up-scaling the quantity to be purchased, the cost will be reduced accordingly: so
far, starting from the formulation here reported, the production cost of sakacin A is likely to be lower
than that reported here. Taking into account that the limited use of bacteriocins in the production
of antimicrobial materials for food packaging solutions is mainly due to their high production
cost, the obtained reduction may widen the range of applications of these molecules as antilisterial
food-grade compounds.
Mapelli et al. [29] set-up an antilisterial packaging material, based on sakacin A incorporated
in cellulose nano-fibers (CNF), and demonstrated its antimicrobial activity on smoked salmon fillets
intentionally inoculated with Listeria. The active material was prepared at a sakacin A concentration of
around 50 AU/cm2 employing a culture medium with a formulation cost of around 8.06 €/106 AU; at
the reported conditions, production cost of the active mat in terms of sakacin A content resulted around
4.03 €/m2. With the here proposed new culture medium formulated with liquid CWP, bacteriocin
production cost can be reduced from 2.33 to 1.53 €/L (5.67 €/106 AU), with a cost reduction of the active
material up to 2.84 €/m2 (−30%).
Biomolecules 2020, 10, 597 10 of 12
4. Conclusions
The present paper contributes to CWP valorization by applying the circular economy concepts
expressed by de la Caba et al. [29]. This required a food industry by-product to produce antimicrobials
for food preservation. This residue has been used to optimize a culture medium formulation suitable
for the production of sakacin A, bacteriocin with a specific antilisterial activity obtained by Lactobacillus
sakei. The six best formulations identified as effective in maximizing sakacin A production yield,
significantly differed for their bacteriocin production cost. From an economic perspective the culture
medium did not always give the highest bacteriocin production titre has the cheapest formulation.
The research highlighted up to 70% decrease of sakacin A production costs can be reached compared
to what obtainable in the MRS reference medium, and even in the other already published papers.
This reduction will pave the way for the possibility of extending the use of sakacin A as natural
antimicrobial in the production of active packaging solutions to face the risk of Listeria monocytogenes
outbreaks in food items.
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